Hypothesis: can kojic acid prevent xanthelasma formation?
Namazi
M R
MR
Sharifian
M
M
D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use*; D002614:Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D005141:Eyelid Diseases / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008077:Lipoproteins, LDL / Q000187:drug effects; D011753:Pyrones / Q000494:pharmacology / Q000627:therapeutic use*; D012880:Skin Pigmentation / Q000187:drug effects; D016896:Treatment Outcome; D014973:Xanthomatosis / Q000188:drug therapy* / Q000503:physiopathology
D000975:Antioxidants; D002614:Chelating Agents; D008077:Lipoproteins, LDL; D011753:Pyrones; C011890:kojic acid